Ultragenyx to Participate in Investor Conferences in December
Provided By GlobeNewswire
Last update: Nov 26, 2024
NOVATO, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultrarare genetic diseases, today announced participation in three upcoming investor conferences.
Read more at globenewswire.com
